ZyVersa Therapeutics Inc (ZVSA)
1.06
-0.01
(-0.93%)
USD |
NASDAQ |
Nov 27, 14:35
ZyVersa Therapeutics Shares Outstanding: 2.344M for Nov. 11, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
November 11, 2024 | 2.344M |
September 30, 2024 | 1.074M |
September 16, 2024 | 1.074M |
September 04, 2024 | 1.074M |
August 30, 2024 | 1.074M |
August 08, 2024 | 1.029M |
July 11, 2024 | 0.8349M |
June 30, 2024 | 0.8349M |
May 10, 2024 | 0.8349M |
April 26, 2024 | 0.8349M |
March 31, 2024 | 0.8349M |
March 21, 2024 | 0.7595M |
March 15, 2024 | 0.7595M |
February 13, 2024 | 0.4632M |
December 31, 2023 | 0.4052M |
December 11, 2023 | 0.1643M |
December 05, 2023 | 0.1243M |
December 01, 2023 | 0.1243M |
November 17, 2023 | 0.1243M |
November 10, 2023 | 0.1243M |
November 01, 2023 | 0.1243M |
October 23, 2023 | 0.1243M |
Date | Value |
---|---|
October 20, 2023 | 0.1243M |
September 30, 2023 | 0.1243M |
September 29, 2023 | 0.1243M |
September 14, 2023 | 0.1243M |
September 11, 2023 | 0.104M |
August 16, 2023 | 0.0883M |
July 26, 2023 | 0.0769M |
June 30, 2023 | 0.0676M |
June 13, 2023 | 0.0676M |
June 12, 2023 | 0.0676M |
June 05, 2023 | 0.0665M |
May 10, 2023 | 0.0578M |
April 28, 2023 | 0.0578M |
April 11, 2023 | 0.0263M |
April 03, 2023 | 0.0263M |
March 31, 2023 | 0.0263M |
March 23, 2023 | 0.0263M |
March 09, 2023 | 0.0263M |
January 13, 2023 | 0.0261M |
December 31, 2022 | 0.0259M |
December 13, 2022 | 0.0259M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
0.0259M
Minimum
Dec 13 2022
2.344M
Maximum
Nov 11 2024
0.3838M
Average
0.1243M
Median
Sep 14 2023
Shares Outstanding Benchmarks
NeuroBo Pharmaceuticals Inc | 8.616M |
Dermata Therapeutics Inc | 2.041M |
Cognition Therapeutics Inc | 41.55M |
NovaBay Pharmaceuticals Inc | 4.886M |
Palatin Technologies Inc | 19.55M |